ADIPOQ and metabolic syndrome: In patients with metabolic syndrome this “adipo-vascular axis" expresses itself in lower plasma levels of adiponectin and higher plasma levels of IL-6 that could be linked to the development of arterial stiffness and to the pathogenesis of ischemic stroke through microvascular and inflammatory mechanisms.